Related Experiment Video
Updated: Jun 2, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Gemcitabine monotherapy associated with posterior reversible encephalopathy syndrome
Luiz Carlos Porcello Marrone1, Bianca Fontana Marrone, Julia de la Puerta Raya
1Instituto do Cérebro, Porto Alegre, Brazil.
Abstract:
Posterior reversible encephalopathy syndrome is a clinicoradiologic entity that may present with headaches, altered mental status, seizures and visual loss as well as specific neuroimaging findings. We report a case of a 74-year-old woman receiving adjuvant gemcitabine chemotherapy as monotherapy for a stage IIa pancreatic adenocarcinoma, who developed posterior reversible encephalopathy syndrome.
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Cryptococcal Meningitis
Hepatic Encephalopathy
Treatment Resistent Cancers
Cytomegalovirus Disease
Encephalitis l: Introduction